- Trials with a EudraCT protocol (2,921)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
2,921 result(s) found for: Health effects.
Displaying page 1 of 147.
| EudraCT Number: 2011-005439-20 | Sponsor Protocol Number: 1 | Start Date*: 2012-01-05 |
| Sponsor Name:Dept of Renal medicine | ||
| Full Title: A randomised, double-blind study to investigate the effects of intramuscular testosterone undecanoate (Nebido®) on anemia treatment in testosterone deficient men undergoing hemodialysis. | ||
| Medical condition: Hypogonadal males undergoing hemodialysis (HD). | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-004109-18 | Sponsor Protocol Number: 15SM2947 | Start Date*: 2015-11-05 |
| Sponsor Name:Imperial College London | ||
| Full Title: Self-Assessment Method for Statin side-effects Or Nocebo (SAMSON) trial. | ||
| Medical condition: Primary and secondary prevention of hyperlideamia. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-001088-11 | Sponsor Protocol Number: s56489 | Start Date*: 2014-07-29 |
| Sponsor Name:MEDA | ||
| Full Title: Academic study on the effects of MP 29-02 nasal spray on inflammatory mediators in allergic rhinitis | ||
| Medical condition: Allergic rhinitis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-000045-40 | Sponsor Protocol Number: Lachgasv1.0 | Start Date*: 2018-03-08 |
| Sponsor Name:Universitair ziekenhuis Brussel | ||
| Full Title: The effects of nitrous oxide on human vision | ||
| Medical condition: effects on vision: - accomodation - visual acuity - binocularity - stereopsis - colour vision - pupil reflex - eye movements | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2022-003266-21 | Sponsor Protocol Number: PSY-NIL-0012 | Start Date*: 2023-03-31 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: Acute effects of ketamine on the glutamatergic NMDA receptor quantified by PET and the radioligand (R)-[11C]-Me-NB1 | ||
| Medical condition: Acute effects of ketamine | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2018-003945-40 | Sponsor Protocol Number: EPU-P112 | Start Date*: 2019-04-10 |
| Sponsor Name:Maastricht University | ||
| Full Title: EFFECTS OF VAPORISED CANNABIS, WITH AND WITHOUT CBD, ON DRIVING AND COGNITION | ||
| Medical condition: This study will look at the differential effects of variations in cannabis chemovars on driving ability and cognition | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-000666-35 | Sponsor Protocol Number: AGO/2011/002 | Start Date*: 2011-03-21 |
| Sponsor Name:Ghent University Hospital | ||
| Full Title: Analysis of the effect and side effects of desmopressin melt in patients with nocturnal polyuria. | ||
| Medical condition: Nocturia and noctural polyuria | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001434-35 | Sponsor Protocol Number: Hydroxycholoquin-COVID-19 | Start Date*: 2020-03-31 |
| Sponsor Name:Cliniques universitaires Saint-Luc | ||
| Full Title: Monocentric Population Pharmacokinetic study of Hydroxychloroquine in COVID-19 Patients to inform its dosing optimization. | ||
| Medical condition: Subject tested positive for COVID-19 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001813-18 | Sponsor Protocol Number: AOI_2019_JABAUDON | Start Date*: 2020-07-29 |
| Sponsor Name:CHU de CLERMONT-FERRAND | ||
| Full Title: Randomized Clinical Trial of Inhaled Sedation with Sevoflurane in Critically Ill Patients at Risk of Developing the Acute Respiratory Distress Syndrome | ||
| Medical condition: Patients in ICU with risks of Acute Respiratory Distress Syndrome | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-002471-18 | Sponsor Protocol Number: | Start Date*: 2019-01-18 | |||||||||||
| Sponsor Name:Imperial College London | |||||||||||||
| Full Title: The clinical effectiveness and cost effectiveness of clozapine for inpatients with borderline personality disorder: randomised controlled trial | |||||||||||||
| Medical condition: Borderline Personality Disorder | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-002901-30 | Sponsor Protocol Number: AGO/2006/006 | Start Date*: 2006-06-22 |
| Sponsor Name:University Hospital Ghent | ||
| Full Title: Tramadol iv. : influence of dose and dose intervals on therapeutic accuracy and side effects when used for postoperative pain relief in ambulatory surgery | ||
| Medical condition: ASA I and II | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-014402-33 | Sponsor Protocol Number: P50 | Start Date*: 2009-09-21 |
| Sponsor Name:European Commission | ||
| Full Title: Effects of dronabinol (Marinol(R)) on actual driving, simulated driving and Standardized Field Sobriety Test | ||
| Medical condition: To assess the effects of dronabinol 10 and 20 mg on driving performance in healthy volunteers | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-004803-39 | Sponsor Protocol Number: SA-NXY-0007 | Start Date*: 2005-10-07 |
| Sponsor Name:AstraZeneca AB | ||
| Full Title: SAINT II (Stroke - Acute Ischemic - NXY Treatment) A double blind, randomized, placebo controlled, parallel group, multicenter, phase IIb/III study to assess the efficacy and safety of intravenous ... | ||
| Medical condition: Acute ischemic stroke. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) HU (Completed) SK (Completed) ES (Completed) BE (Completed) DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-000676-33 | Sponsor Protocol Number: 292004 | Start Date*: 2006-09-14 |
| Sponsor Name:NV Organon | ||
| Full Title: A randomized, open-label, comparative, multi-center trial to evaluate the effects on hemostasis, lipids and carbohydrate metabolism, and on adrenal and thyroid function of a monophasic COC containi... | ||
| Medical condition: Hormonal oral contraception in healthy women | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-002216-28 | Sponsor Protocol Number: A3711028 | Start Date*: 2005-01-13 |
| Sponsor Name:Pfizer Limited | ||
| Full Title: A multi-center, multinational, randomized, double-blind, placebo-controlled, proof of concept trial to assess the effects of a subject-optimized dose of UK-369,003 Modified Release on exercise capa... | ||
| Medical condition: Pulmonary hypertension associated with chronic obstructive pulmonary disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) DE (Completed) BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-000990-35 | Sponsor Protocol Number: FARM12.PW7R_A6-DeprEpil | Start Date*: 2019-02-06 | |||||||||||
| Sponsor Name:DIP. MEDICINA DEI SISTEMI UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA | |||||||||||||
| Full Title: EFFECTS OF ANTIDEPRESSANT TREATMENT WITH AGOMELATINE ON PATIENTS AFFECTED BY DEPRESSION AND EPILEPSY. A DOUBLE BLIND RANDOMIZED STUDY WITH ACTIVE CONTROL (ESCITALOPRAM) WITH PARALLEL GROUPS. | |||||||||||||
| Medical condition: Depression in patients affected by epilepsy | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-002977-12 | Sponsor Protocol Number: EPUP81 | Start Date*: 2014-10-08 |
| Sponsor Name:Maastriccht University | ||
| Full Title: BRAIN KINETICS OF NEUROTRANSMISSION DURING THC INTOXICATION | ||
| Medical condition: Brain functioning during THC intoxication | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-003171-64 | Sponsor Protocol Number: M16-534 | Start Date*: 2018-10-30 | |||||||||||
| Sponsor Name:AbbVie Deutschland GmbH & Co.KG | |||||||||||||
| Full Title: Phase 3b Study for Management of Ocular Side Effects in Subjects with EGFR-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin (ABT-414) | |||||||||||||
| Medical condition: EGFR-Amplified Newly diagnosed glioblastoma | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) NL (Completed) DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-001328-21 | Sponsor Protocol Number: ABR65448 | Start Date*: 2019-01-08 |
| Sponsor Name:Leiden University Medical Center | ||
| Full Title: Chronotherapy with aspirin for reduction of cardiovascular disease | ||
| Medical condition: The medical condioton to be investigated is recurrent cardiovascular disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-005355-32 | Sponsor Protocol Number: IIV-275 | Start Date*: 2014-03-06 |
| Sponsor Name:National Institute for Public Health and the Environment (RIVM, the Netherlands) | ||
| Full Title: Memory response against Bordetella pertussis in adults: immunological effects of an acellular pertussis booster vaccination | ||
| Medical condition: The vaccine administered in this study is used to prevent pertussis caused by the bacterium Bordetella pertussis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.